AstraZeneca Signs AI Deal To Pursue Novel Parkinson's Drugs
Aug 29 2017
•
By
Lucie Ellis-Taitt
AstraZeneca To Boost Early-Stage CNS Pipeline Via AI Drug Discovery Deal
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Deals
More from Business
